Cite
HARVARD Citation
Shephard, A. et al. (2015). Randomised, double‐blind, placebo‐controlled studies on flurbiprofen 8.75 mg lozenges in patients with/without group A or C streptococcal throat infection, with an assessment of clinicians' prediction of 'strep throat'. International journal of clinical practice. 69 (1), pp. 59-71. [Online].